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Abstract
A family of multipotent heart progenitors plays a central role in the generation of diverse
myogenic and nonmyogenic lineages in the heart. Cardiac progenitors in particular play a
significant role in lineages involved in disease, and have also emerged to be a strong ther-
apeutic candidate. Based on this premise, we aimed to deeply characterize the progenitor
stage of cardiac differentiation at a single-cell resolution. Integrated comparison with an
embryonic 5-week human heart transcriptomic dataset validated lineage identities with
their late stage in vitro counterparts, highlighting the relevance of an in vitro differentia-
tion for progenitors that are developmentally too early to be accessed in vivo. We utilized
trajectory mapping to elucidate progenitor lineage branching points, which are supported
by RNA velocity. Nonmyogenic populations, including cardiac fibroblast-like cells and
endoderm, were found, and we identified TGFBI as a candidate marker for human cardiac
fibroblasts in vivo and in vitro. Both myogenic and nonmyogenic populations express
ISL1, and its loss redirected myogenic progenitors into a neural-like fate. Our study pro-
vides important insights into processes during early heart development.
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1 | INTRODUCTION
Cardiogenesis is a complex process involving a family of multipotent
cardiac progenitors. Single-cell RNA sequencing (scRNA-seq) studies
have revealed temporal and spatial expression patterns of embryonic
cardiac populations.1-5 Compared with murine cardiogenesis, our
knowledge on early human progenitor lineages is limited. Two recent
studies provided fundamental understandings of the human fetal
heart in single-cell resolution.6,7 However, since the heart is the first
organ to develop, the earliest human samples that can be feasibly col-
lected do not cover the onset of cardiogenesis, and therefore, the ear-
liest human progenitor populations have remained elusive. Cardiac
induction of human pluripotent stem cells (hPSCs) has emerged as an
important model system for early human cardiogenesis and disease
modeling.8-10 Furthermore, a recent study supports the application of
hPSC-derived cardiac progenitors as a viable alternative to mature
cardiomyocytes in regenerative medicine.11
Recent efforts have characterized transcriptional snapshots of the
cardiomyocyte and other lineages during hPSC cardiac induction by
RNA sequencing.7,12-16 These studies suggest in vitro cardiac differenti-
ation resembles the early human heart development, and that in vitro
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cardiomyocyte differentiation protocols also generate nonmyogenic cell
types.12,13 However, the transient differentiation dynamics of myo-
genic and nonmyogenic lineages is not fully described.
Therefore, we focused on the transient cellular identities of early
cardiac progenitors through lineage and time. We generated Smart-
Seq2 scRNA-seq libraries of cells collected from human embryonic
stem cell (hESC) cardiac induction using a widely adopted Wnt-
modulation based differentiation protocol.8,10 We identified cardiac dif-
ferentiation and nonmyogenic cell types, and verified in vitro cell identi-
ties by directly integrating with a human fetal cell dataset published by
Cui et al.1 Trajectory analysis using different methods connected line-
age heterogeneity through time, and identified lineage branching
points, which we confirmed used RNA velocity, also confirming lineage
directionality.17 From this analysis, TGFBI emerged as a candidate
marker for cardiac fibroblasts in vitro and in vivo. Lastly, we investi-
gated the role of ISL1 in both myogenic and nonmyogenic progenitors.
Taken together, our study highlights the importance of early progenitor
model systems that allows us to study otherwise inaccessible progeni-
tor cells in vivo. Our findings provide a valuable reference for using
hESC cardiac induction as a platform for genetic studies and disease
modeling.
2 | MATERIALS AND METHODS
2.1 | Maintenance and cardiac differentiation of
hESCs
ES03 hESCs were maintained in Essential 8 Flex Medium (Thermo Fisher
Scientific) on Matrigel (Corning, Germany) coated six-well plates and pas-
saged in Versene (Thermo Fisher Scientific). The cardiac differentiation
protocol was adapted from Lian et al.9
2.2 | Smart-Seq2 library preparation and
sequencing
Cells were manually picked using a hand-pulled capillary needle and trans-
ferred into Smart-Seq2 lysis buffer with ERCC RNA spike-in mix and
snap-frozen. Single-cell libraries were processed into cDNA libraries by
following the Smart-Seq2 protocol.18,19 Library quality control was per-
formed using Bioconductor and Qubit for fragment size and concentration.
Barcodes were added using Illumina Nextera XT DNA sample preparation
kit with dual indexes. Libraries were pooled into batches and sequencing
was performed on Illumina HiSeq 2500 for 50 bp single-end reads.
2.3 | Single-cell RNA sequencing data analysis
Raw sequencing reads were de-multiplexed using bcl2fastq and
mapped to the human hg38 genome using TopHat. For quality con-
trol, cells with less than 7000 detected genes were excluded. Filtering,
normalization, and subsequent analyses were performed as described
in the Seurat 3.0 R package tutorial, followed by dimensional reduc-
tion and clustering, marker gene identification and cell-cycle scoring.
Integration of in vitro and in vivo datasets was performed following
the standard workflow for data integration and label transfer in
Seurat.
Monocle pseudotime analysis was performed following the online
tutorial. The Monocle pseudotime values were imported into the Seu-
rat object and visualized to confirm the correlation between different
analysis methods. STRING and PANTHER online analysis tools were
used for functional enrichment analyses. Force-directed graphing
(FDG) was performed using the igraph R package, and the nearest
neighbor matrix was calculated using the method described by Kee
et al.20 RNA velocity calculations were performed according to the
Velocyto tutorial. In brief, a .loom file with counts divided in spliced/
unspliced/ambigious was produced in Python using the human hg38
genome annotation file and an expressed repeat annotation file from
the UCSC genome browser. Subsequent RNA velocity analysis was
performed according to Le Manno et al.17
2.4 | Immunohistochemistry and
immunocytochemistry
Cardiac tissue sections were permeabilized in 0.5% Triton X-100,
blocked (3% BSA, 3% normal donkey or goat serum in phosphate-
buffered saline [PBS]) and incubated with primary antibodies in block-
ing buffer overnight. Sections were incubated with secondary anti-
bodies in blocking buffer and counterstained with 40 ,6-diamidino-
2-phenylindole (DAPI).
Cells grown on cover slips were fixed with 4% paraformaldehyde,
permeabilized with 0.5% Triton X-100, and blocked with 3% BSA in
PBS. Cells were incubated with primary antibodies in blocking buffer
overnight, followed by incubation with secondary antibodies and
nuclear counterstaining with DAPI.
Following antibodies were used in this study: HHEX (HPA051894,
Atlas Antibodies), ISL1 (39.4D5, DSHB), NKX2-5 (sc-14 033, Santa Cruz),
TFAP2A (ab108311, Abcam), TGFBI (ab66957, Abcam), TNNT2 (MS-
295-P1, Thermo Fisher Scientific), and vimentin (AB5733, Millipore).
Significance statement
Despite the large interest in defining the transcriptional pro-
files of human cardiac cells in single-cell resolution, the tran-
sient stages of early human cardiac progenitors have
remained elusive. This article defines the differentiation and
lineage branching points of human embryonic stem cells into
cardiomyocytes, endoderm, and cardiac fibroblast-like cells,
and elucidates the role of ISL1 in the development of these
cell types. Genetic perturbation studies found that ISL1 may
be required to suppress a neural-like cell fate in myogenic
progenitors.
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2.5 | Human fetal heart tissue
Human fetal hearts at 6.5 and 10 weeks of gestation were obtained
from authorized sources in Karolinska University Hospital with
an approved ethical permission (2015/1369-31/2) and appropriate
informed consents. The fetal hearts were snap-frozen and
cryosectioned at 10 μm thickness for immunostaining.
2.6 | Genetic manipulation of hESCs
Genetic manipulation of ES03 hESCs was performed using the
CRISPR/Cas9 system. Briefly, two guide RNAs targeting exon 4 were
designed and cloned into PB/CRISPR vector. Three plasmids, pPB-
CRISPR-ISL1-g1,-g2 and pCyL43, were transfected into hESCs using
B-16 program in Nucleofector 2b device. After 2 weeks of puromycin
selection, cells were singularized and seeded to generate single-cell-
derived colonies. Single-cell clones were picked, expanded, and gen-
otyped. Loss of ISL1 expression was verified using standard quantita-
tive PCR (qPCR), immunoblotting, and immunocytochemistry
methods. Decreased expression of cardiomyocyte marker TNNT2 was
detected by flow cytometry after 14 days of cardiac differentiation.
See supplementary methods for further details for experimental
procedures and data analysis.
3 | RESULTS
3.1 | Single-cell RNA sequencing reconstructs a
temporal axis and reveals distinct phases of human
cardiomyocyte differentiation
To rigorously characterize the transient cellular identities during early
human cardiomyocyte differentiation, we used a widely adopted pro-
tocol9 that generates 70% to 90% cardiac troponin (TNNT2)
expressing cardiomyocytes from karyotypically normal hESCs (supple-
mental online Figure 1A,B). Following this protocol, beating cells are
first observed around day 8. In order to capture a diverse spectrum of
cellular states, we harvested cells spanning from cardiac mesoderm
and nonbeating cardiovascular progenitors (days 3-7) to beating car-
diac progenitors (days 8 and 9) and phenotypically immature, but
functionally competent beating cardiomyocytes (day 15) (Figure 1A).
Cells were picked manually from two differentiation batches and in
total 1024 Smart-Seq2 single-cell libraries were prepared for scRNA-
seq,18,19 of which 925 cells passed the quality control. RNA spike-ins
used in the library preparation confirmed low technical variability
between libraries (supplemental online Figure 1C), and the number of
genes detected per cell was as expected in both batches (supplemen-
tal online Figure 1D).
We proceeded with the Seurat version 3.0 package21-23 and
STRING version 11.0 gene ontology (GO)24 for downstream analyses.
The top variable genes across the dataset were associated with devel-
opmental processes, chromatin assembly, and muscle contraction
(supplemental online Figure 1E). Principal component analysis of the
gene-set (supplemental online Table 1) reconstructed a temporal axis
along principal component one (PC1), which was supported by TNNT2
expression (Figure 1B). Analysis of global transcriptional dynamics
across time showed that the batteries of gene expression differ signif-
icantly between days 3 and 6 (supplemental online Figure 1F). This
suggests that up until day 6 the cells rapidly progress through tran-
sient and distinct cellular states, until they reach day 7 where the cel-
lular identity becomes relatively stable.
To partition the cells into distinct populations, unsupervised clus-
tering was performed based on principal components 1-9, and visual-
ized on a t-distributed neighbor (t-SNE) projection (Figure 1C,D).
Statistically significant (Wilcox test, adjusted P-value <.05) positive
marker genes were identified for each cluster (supplemental online
Table 2) and visualized in a heatmap (Figure 1E). GO analysis and liter-
ature review were used to identify biological processes and cell sub-
populations (supplemental online Table 3).
Based on marker gene expression (supplemental online Table 2),
cluster 0 (C0) consists of pluripotent cells, C1 represents cardiac
mesoderm, C2 and C3 represent early cardiac progenitors. C2 and C3
differ in that C3 expresses cell-cycle and proliferative markers. C4 and
C5 represent late cardiac progenitors and cardiomyocytes, respec-
tively. C6 potentially consists of proapoptotic myogenic cells, which
remained after stringent quality control (see the Methods section). C7
consists of nonmyogenic cells expressing fibroblast and epithelial
markers. C8 consists of definitive endoderm-like cells.
Based on the distribution of cell types found in each time point, a
myogenic population dominated the differentiation. Pluripotent and
mesoderm populations persisted in the differentiation until day
6, when fibroblast-like cells began to emerge and persisted until
day 15 and possibly beyond. Endoderm-like cells appeared from day
4 onward and were no longer detected by day 15 (Figure 1F). This is
also reflected in the expression of pluripotency, cardiac mesoderm,
cardiac transcription factor, and sarcomeric marker genes (Figure 1G).
Overall myogenic populations are marked by CDH2 and nonmyogenic
populations are marked by CDH1 expression (supplemental online
Figure 1G). Furthermore, Monocle pseudotime analysis25-27 of the
pluripotent and myogenic cells (clusters 0-5) revealed a continuous
cardiomyocyte differentiation axis (supplemental online Figure 1H).
Taken together, different stages of myogenic and nonmyogenic
lineage differentiation were reconstructed for further downstream
analysis.
3.2 | Direct transcriptional comparison between
hESC-derived cardiac cells and the human fetal heart
In vitro-derived cardiac populations have long been associated with
in vivo lineages based on selected expression markers and functional
parameters. To comprehensively compare the two on a global trans-
criptomic level, we leveraged a human fetal dataset1 to compare
5-week fetal heart cells with in vitro-generated cells. We integrated
our in vitro dataset with the in vivo (5W) dataset1 using Seurat 3.0,
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which accounts for different scRNA-seq modalities and parameters
such as gene counts per cell21,23 (see the Methods section) (supple-
mental online Figure 2A,B). The 5W fetal heart cells did not cluster
together with in vitro time points earlier than day 8, but were tran-
scriptionally most similar with in vitro cells across days 8, 9, and
15 (supplemental online Figure 2B). Therefore, we specifically com-
pared 5W cells with day-8, -9, and -15 cells, since there may be a level
of asynchronicity across days 8, 9, and 15. To connect the in vivo line-
ages with their in vitro counterparts, we performed unsupervised clus-
tering on a t-SNE projection (Figure 2A) and GO analysis
(supplemental online Figure 2C, Tables 4 and 5). Clustering analysis
revealed similar transcriptional profiles between several populations
of human fetal and hESC-derived cells, including ventricular
cardiomyocytes (integrated cluster 0; IC0), atrial cardiomyocytes (IC1),
F IGURE 1 Temporal single-cell
profiling of human embryonic stem cell
(hESC) cardiac induction. A, Schematic
representation of hESC cardiac
differentiation, with sample collection days
indicated in blue. B, PCA plots for
925 cells and 2000 differentially
expressed genes. Colors represent time
point and TNNT2 expression. C, D, T-SNE
representation of clusters. C, Colors
represent clusters. D, Colors represent
time point. E, Expression heatmap of the
top differentially expressed genes of each
cluster. F, Percentage of each cell type per
time point: pluripotent (cluster 0),
fibroblast-like (cluster 7), endoderm
(cluster 8), and myogenic (clusters 1-6).
G, Violin plots showing the expression of
marker genes of pluripotency and
mesoderm development (POU5F1 and
MESP1), cardiac transcription factors
(PDGFRA, ISL1, HAND1, HAND2, GATA4,
MEF2C, and NKX2-5), and sarcomeric
genes (TNNT2, MYL7, andMYL3) per day
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F IGURE 2 Single-cell comparison between hESC cardiac induction and human fetal heart development. A, T-SNE clustering of in vitro and
in vivo cells.1 Colors indicate cell origin, that is, time point for in vitro cells and spatial annotations (LA, left atrium; LV, left ventricle; RA, right
atrium; RV, right ventricle) for in vivo cells. B, T-SNE feature plots indicating the expression of example marker genes for different cell types. C,
Fractions of cells from different origins, that is, in vitro time points and in vivo spatial annotations in each cluster. D, Violin plots indicating
ventricular marker gene expression by in vitro and in vivo cells in integrated cluster 0. E, Atrial marker gene expression by in vitro and in vivo cells
in integrated cluster 1. F, Fibroblast marker gene expression by in vitro and in vivo cells in integrated cluster 3. G, Feature plots indicating the
expression of fibroblast marker genes. H, Cell-cycle scores illustrated as a feature plot showing proliferating cells in red. I, Violin plot indicating
specific expression of TGFBI by cluster 7 fibroblast-like cells in the complete in vitro dataset. J, in vitro fibroblast-like cells express TGFBI and
cardiac fibroblast marker vimentin (VIM). K, in vivo fetal cardiac fibroblasts express both TGFBI and VIM
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fibroblast-like cells (IC3), proliferative cardiac progenitors (IC5), and
endothelial cells (IC6) (Figure 2A,B). IC2 and IC4 consist of early car-
diac progenitors and small populations of other cell types. The hESC-
derived endoderm population did not overlap with human fetal cells,
but is included in IC4 as a separate population marked by HNF4A
expression (supplemental online Figure 2D).
IC0 comprises of cells from 5W left and right ventricles and day
15 hESC-derived cardiomyocytes (Figure 2C). IC0 population
expresses ventricle-specific genes such as MYH7 (Figure 2D). IC1 cells
express atrial-specific genes such as MYH6 (Figure 2E) and the cluster
comprises in vivo atrial cells and day-8 and -9 in vitro cells (Figure 2C).
Remarkably, little to no day-15 cells were found in the atrial IC1
(Figure 2A,C). The in vitro cells of IC0 and IC1 correspond to the car-
diomyocyte cluster of the in vitro dataset (C5). This in vivo trans-
criptomic comparison confirms that (a) the Wnt modulation-based
differentiation protocol generates ventricular cardiomyocytes, in line
with previous report,11 and (b) human ventricular progenitors initially
go through an atrial-like transcription program before differentiating
into ventricular cardiomyocytes, in line with mouse studies.28 Interest-
ingly, in vivo ventricular and atrial cells expressed their respective line-
age markers at a higher level compared with their in vitro
counterparts (Figure 2D,E).
IC2 corresponds to the differentiating cardiomyocytes
in vitro and clusters close to both the atrial (IC1) and ventricular
cardiomyocytes (IC0) (Figure 2A). IC3 consists of cardiac fibroblast-
like cells from both in vivo and in vitro (Figure 2B,C), expressing fibro-
blast and epicardial markers (Figure 2F,G, supplemental online
Figure 2E). The in vitro cells in IC3 correspond to the C7 fibroblast-
like cells (Figure 1C). IC4 corresponds to the early cardiac progenitors
in vitro (C2). IC5 is a group of proliferative cardiac progenitors, based
on the expression of G2M cell-cycle markers (Figure 2H), and
expresses highly similar markers compared with IC0 and IC1. IC6 is a
group of endothelial cells expressing PECAM1 (Figure 2B).
We found that TGFBI, a TGF-β-responsive extracellular matrix gene,
strongly marks the hESC-derived cardiac fibroblast-like cells
(C7) (Figure 2I), which we verified by immunostaining TGFBI with fibro-
blast marker vimentin (VIM) and cardiomyocyte marker TNNT2
(Figure 2J). TGF-β signaling pathway plays an important role in the
induction of epithelial-mesenchymal transition during cardiac develop-
ment.29 We found from an additional human fetal single-cell dataset,30
that TGFBI is expressed in fibroblast-like and epicardium-derived cells in
the 6.5 to 7W human fetal heart. We performed TGFBI immunostaining
on human 6.5W and 10W fetal tissue together with VIM and TNNT2
(Figure 2K, supplemental online Figure 3A,B). In line with the sequencing
results, we detected TGFBI and VIM coexpression at both fetal time
points in cardiac ventricles, with expression more abundant in the RV
(supplemental online Figure 3A). Interestingly, in 6.5W RV, TGFBI
expressing cells were located close to epicardium (supplemental online
Figure 3A). Taken together, our results indicate that TGFBI may be a
specific marker of a subset of human embryonic cardiac fibroblasts both
in vivo and in vitro.
In summary, we integrated in vivo and in vitro single-cell trans-
criptomic data to directly compare the two on a transcriptome-wide
level. These analyses verified the cellular identity of in vitro-generated
cells, and further validate the relevance of the hESC-based system to
study early cardiac progenitors that cannot be obtained in vivo.
3.3 | Trajectory mapping reveals branch points in
cardiac differentiation
In order to resolve the lineage relationship between the identified cell
types, we sought to visualize the canonical cardiomyocyte differentia-
tion axis and other noncanonical cell types. We used two methods: (a) a
modified pipeline for graphical analysis by FDG20 based on t-SNE
dimensionality reduction (Figure 3A), and (b) Uniform Manifold Approx-
imation and Projection (UMAP) (Figure 3B).21,23 The original clustering
was preserved on both FDG and UMAP (Figure 3A,B). Assessment of
differences between batches indicates that batch effect is not the
major driver of cellular heterogeneity (supplemental online Figure 4A).
The resulting FDG and UMAP revealed a continuous pluripotent
to cardiomyocyte differentiation trajectory, as well as nonmyogenic
lineages connected to the pluripotent cluster through bridges
(Figure 3A,B). We confirmed the resulting trajectories are in line with
pseudotime values calculated from Monocle (supplemental online
Figure 4B). Both FDG and UMAP analyses indicate that multiple tra-
jectories branch from pluripotent C0 cells (Figure 3A,B): (a) cardiac
mesoderm (C1); (b) endoderm-like (C8); and (c) fibroblast-like
(C7) (Figure 3A-C and supplemental online 4C). The fibroblast-like
population (C7) is marked by TGFBI and TFAP2A, a transcription factor
broadly expressed by ectodermal lineages as well as human cardiac
fibroblasts31 (Figure 3C). Interestingly, a subpopulation of C7 also
expressed SEMA3D, a proepicardial progenitor and neural crest
marker (supplemental online Figure 4C).32 Cells at the beginning of
the HHEX+ endoderm trajectory expressed the early endoderm marker
SOX17, whereas cells located closer to the tip of the trajectory
express markers of endoderm derivatives such as APOA233 (Figure 3C
and supplemental online Figure 4C).
The C1 cardiac mesoderm consists of proliferative and non-
proliferative cells (Figure 3D). Interestingly, the nonproliferative C1
cells showed higher ISL1 expression (Figure 3C). The C1 cardiac meso-
derm is connected to the C2 early cardiac progenitors, which repre-
sent the well-studied ISL1 human cardiac progenitor.30,34 Our
trajectory mapping reconstructed a branching point at the C2 ISL1+
early cardiac progenitors. Distinct trajectories emerge from the ISL1+
population: a small group of endothelial cells marked by
PECAM1expression (Figure 3C); a proliferative population of cells
showing similar transcriptional profile as the C2 population (C3); and a
trajectory of late cardiac progenitors and cardiomyocytes (C4 and C5)
(Figure 3C, supplemental online Figure 4C). In addition, a population
of smooth muscle-like cells marked by ACTA2 expression was found
embedded in the cardiomyocyte cluster (Figure 3C). Within the C2
ISL1+ early cardiac progenitor, where the above populations stem
from, we found a significant enrichment of extracellular matrix genes,
such as COL3A1. COL3A1 was also coexpressed with myogenic line-
age markers PDGFRA and NKX2-5 (Figure 3C,E). To validate the
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protein expression, we performed immunostaining of COL3A1, ISL1,
and NKX2-5, which indicated that ISL1 progenitors expressed
COL3A1 (Figure 3F).
We found that different cell populations were captured in vari-
ous proliferative states. Therefore, we wanted to normalize the
cell-cycle heterogeneity in order to account for the true trans-
criptomic differences between cell populations. We assigned each
cell a cell-cycle score (G2M score), based on their expression of
markers of G2 and M phase of the cell cycle (see the Methods
section) (Figure 3D,G).
F IGURE 3 Trajectory analysis draws a
detailed lineage map of hESC cardiac
differentiation. A, T-SNE, FDG, and B, UMAP
representation of single-cell
transcriptomes. C, Example marker gene
expression. Markers for pluripotency
(POU5F1), fibroblast-like population (TFAP2A
and TGFBI), mesendoderm (TBXT), endoderm
(HHEX), mesoderm (MESP1), cardiac
progenitors (ISL1 and COL3A1), late cardiac
progenitors (NKX2-5), cardiomyocytes (MYL3),
smooth muscle-like cells (ACTA2) and
endothelial cells (PECAM1). D, Feature plot
indicating cells with positive cell-cycle scores
for G2 and M phase. E, Scatter plots
indicating that COL3A1 is coexpressed with
ISL1, PDGFRA, and NKX2-5 in cardiac
progenitors. F, Immunostaining indicating
coexpression of COL3A1 with ISL1 and
NKX2-5 in the cardiac progenitors. G,
Percentages of cells with G2M scores >0 in
each cluster. H, Original and cell-cycle
regressed UMAP. Colors represent day and
marker gene expression. I, Violin plot showing
the expression of cadherin (CDH11), Wnt-
related (FZD2, WNT5A, and SFRP1) and
integrin signaling-related (COL3A1, COL5A2,
COL1A1, and COL1A2) genes in clusters
1, 2, and 4
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We observed that the C3 early cardiac progenitor population was
the most proliferative population in our dataset. Since C2 and C3 are
otherwise highly similar in their transcriptional identity, we hypothe-
sized that this cell-cycle heterogeneity skewed the appearance of the
myogenic lineage trajectory, and to mitigate the effect, we regressed
out the cell-cycle phase scores and repeated clustering (see the
Methods section). The resulting UMAP is highly similar except the C2
and C3 early cardiac progenitors are now fused together (Figure 3H).
Together C2 and C3 likely represent the well-studied ISL1+ human
cardiac progenitor,30,34 and the cell-cycle regressed trajectory sug-
gests C2 and C3 collectively contribute to the cardiomyocyte differ-
entiation trajectory (Figure 3H).
Next, we aimed to identify signaling pathways regulating lineage
progression of the myogenic axis (C1, C2, and C4 specifically). Top
100 statistically significant marker genes of C1 and C2 were used as
input for Panther pathway analysis tool.35,36 We visualized the results
within the three populations: cardiac mesoderm (C1), early cardiac pro-
genitor (C2), and late cardiac progenitor (C4) (Figure 3I, supplemental
online Table 6). Within C1, pathway analysis indicated significant enrich-
ment of cadherin, angiogenesis, and Wnt signaling pathways. C1
showed specific expression of cadherin-11 (CDH11) (Figure 3I), a cell-
cell adhesion molecule marking endothelial and endocardial cells, as well
as mesenchymal smooth muscle cell progenitors.37 In contrast to C1,
C2, and C4 showed enrichment of integrin signaling-related genes, such
as specific collagens (Figure 3I), suggesting that specific extracellular
matrix-related genes play a role in myogenesis. Taken together, the car-
diac mesoderm population has a highly active Wnt signaling pathway,
whereas the specification of cardiac mesoderm into committed cardiac
progenitors is characterized by increased integrin signaling.
In summary, the high temporal resolution of the data allowed the
reconstruction of a continuous trajectory map of cardiac differentiation.
Lineage trajectories could be defined, and the ISL1+ human cardiac pro-
genitor was found to be at a branching point between endothelial, car-
diomyocyte, and smooth muscle lineages, in line with previous reports.34
Furthermore, we observed that the ISL1+ progenitors coexpressed specific
extracellular matrix genes, which may play a role during development.
3.4 | RNA velocity confirms the existence of
lineage branch points based on the detection of
pre-mRNA
Trajectory analysis does not fully uncover the developmental dynamics of
the differentiation process. RNA velocity, the time derivative of gene
expression, can be used to predict the future state of individual cells by
distinguishing between spliced and unspliced mRNAs.17,38 Importantly,
RNA velocity would also add directionality to the lineage trajectories.
Based on this concept, using the detection of pre-mRNA sequences inher-
ent in the dataset, we sought to generate lineage predictions, in order to
study the transcriptional dynamics and to verify lineage trajectories.
We compared several methods to produce RNA velocity esti-
mates provided by Le Manno et al, and found very similar results (see
the Methods section) (supplemental online Figure 5). We visualized
the RNA velocity calculations as a vector field showing regional aver-
age RNA velocities on the t-SNE, FDG, and UMAP plots, the length
indicating the speed of the differentiation events (Figure 4A-C).
As expected, RNA velocity vectors of the C0 pluripotent popula-
tion points toward the C1 mesoderm cells. The C7 fibroblast-like
lineage has RNA velocity vectors pointing away from C0 and the
other lineages, indicating that it is independent from the myogenic
and endoderm trajectories.
Interestingly, RNA velocity vectors within the C1 cardiac meso-
derm pointed backward in pseudotime, suggesting they might be
maintaining an undifferentiated progenitor phenotype.
The C2 early cardiac progenitors have a relatively stable cellular
state as indicated by short RNA velocity vectors, in contrast to the
cardiomyocytes and endothelial cells, which have RNA velocity vec-
tors pointing away from the C2 progenitors. The late cardiac progeni-
tors and cardiomyocytes (C4 and C5) have RNA velocity vectors
pointing toward the tip of the myogenic trajectory, suggesting strong
cardiomyocyte lineage commitment.
Taken together, RNA velocity based on the detection of pre-
mRNA provides the directionality of the lineage trajectories, which
could only be inferred in previous analyses.
F IGURE 4 RNA velocity illustrates progenitor dynamics and clarifies trajectory branching points. A-C, RNA velocity based on t-SNE, FDG,
and UMAP. Arrows indicate local average velocity on a regular grid vector field. Color represents time points
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3.5 | ISL1 marks and plays distinct roles in
myogenic and nonmyogenic populations
Given that ISL1 is expressed in the progenitors of both the myogenic
and nonmyogenic trajectories (Figure 3C), we wanted to assess
whether the different lineage progenitors are dependent on ISL1
expression. We confirmed ISL1 protein expression using immunohis-
tochemistry in the C4 myogenic (marked by NKX2.5) lineage, C8
endoderm-like (marked by HHEX) lineage, and the C7 fibroblast-like
(marked by TFAP2A) lineage (Figure 5A).
An ISL1 knockout (KO) hESC line was generated using the
CRISPR/Cas9 system (supplemental online Figure 6A) and the loss of
ISL1 expression was verified (supplemental online Figure 6B). ISL1 KO
hESCs generated less TNNT2+ beating cardiomyocytes by day
14 compared to wild-type (WT) hESCs (Figure 5B). To assess the cell
fate of WT vs ISL1 KO progenitors, we proceeded with scRNA-seq of
F IGURE 5 ISL1 is not required for the generation or proliferation of myogenic progenitors, but loss of ISL1 partially redirects myogenic
progenitors toward a neural-like lineage. A, Immunostaining of ISL1 with lineage markers NKX2-5, TFAP2A, and HHEX at day 6 of hESC cardiac
differentiation. B, Flow cytometry analysis and quantification showing TNNT2 expression at day 14 of cardiac differentiation by WT (n = 8) and
KO (n = 8) cells. Error bars represent standard deviation. C, T-SNE clustering of combined day 6 WT and KO cells. Bar chart shows percentages of
myogenic, neural, and endoderm populations per genotype. D, T-SNE feature plots indicating the expression of myogenic (PDGFRA), endoderm
(HHEX), and neural (MAP2) marker genes in the day 6 WT and ISL1 KO dataset. E, Day 6 WT and ISL1 KO cells projected onto the UMAP of the
full dataset. F, Violin plots indicating the cell-cycle scores of WT and ISL1 KO cells within the myogenic population. G, Violin plots indicating
differential expression between genes related to cardiac differentiation (NKX2-5, MYH6, and NKX2-6) and extracellular matrix organization
(COL2A1 and MMP11) in WT compared with ISL1 KO cells within the myogenic population
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the ISL1 KO and WT cells at day 6. 276 ISL1 KO and 148 WT cells
passed quality control and were used for subsequent analyses.
The majority of day-6 WT cells were myogenic, marked by
PDGFRA, with a small number of endoderm-like cells, marked by
HHEX (Figure 5C,D, supplemental online Figure 6C). In contrast, the
day-6 ISL1 KO cells have a decreased proportion of myogenic progen-
itors (Figure 5C). Instead, the ISL1 KO cells have an ectopic cell popu-
lation expressing genes related to nervous system development, such
as MAP2, ZIC2, SOX2, and PAX3 (Figure 5C,D, supplemental online
Figure 6C). We projected the ISL1 KO cells onto the UMAP of the full
dataset, and found that the neural-like population in the ISL1 KO did
not correspond to any other cell type in the UMAP (Figure 5E). The
ISL1 KO also produced a small number of endoderm-like cells, same as
WT. Therefore, the ISL1 KO studies suggest that ISL1 is not essential
for the myogenic and endoderm lineages, but plays a role in
suppressing a neural transcription program during myogenic
differentiation.
Next, we wanted to determine whether ISL1 expression is
required for the proliferation of myogenic progenitors. Assessment of
cell-cycle differences between the WT and ISL1 KO myogenic progen-
itors indicated a similar percentage of proliferative cells in the ISL1 KO
myogenic lineage compared with the WT (Figure 5F), indicating that
at the progenitor stage, loss of ISL1 does not affect proliferative
capacity. Finally, we found that the expression of cardiogenic genes,
such as NKX2-5 and MYH6, and extracellular matrix organization-
related genes, such as COL2A1 and MMP11, was significantly
decreased in the ISL1 KO myogenic population compared to WT myo-
genic population (Figure 5G). We confirmed the decreased cardio-
genic and extracellular matrix-related gene expression in days 6 and
10 by qPCR in several differentiation batches (supplemental online
Figure 6D). In addition, qPCR analysis of endoderm markers indicated
that the loss of ISL1 did not significantly affect endoderm differentia-
tion in the in vitro differentiation.
Taken together, our results indicate that (a) ISL1 is not required
for the generation of myogenic progenitors, but it plays an important
role in suppressing a neural-like transcription program; (c) loss of ISL1
does not affect the proliferative capacity of myogenic progenitors;
and (c) in the absence of ISL1 the expression of extracellular matrix-
related and cardiogenic genes in myogenic progenitors are decreased.
4 | DISCUSSION
Cardiac induction of hESCs is routinely used for tissue engineering,
regenerative medicine, and genetic perturbation studies. The cardiac
induction protocol can also be manipulated to produce specific cellular
subtypes, but this requires detailed knowledge of the signaling path-
ways involved in the lineage specification. Despite recent single-cell
studies of the in vitro differentiation, the transient progenitors and lin-
eage branch points have remained elusive.
This study captured day-by-day transcriptional changes covering
the transition of pluripotent cells into cardiomyocytes and other cell
types. High temporal resolution allowed us to connect the temporal
snapshots into a continuous trajectory map, providing several impor-
tant insights such as lineage branching points verified by pre-mRNA
detection. Dimensional reduction techniques allowed us to generate a
pseudotemporal ordering of cells, illustrating the differentiation and
branching of pluripotent cells into mesoderm and endoderm, as well
as ISL1+ early cardiac progenitors into cardiomyocytes and endothelial
cells. RNA velocity17 was overlaid onto the trajectory map, confirming
the pseudotemporal directionality. The population at the developmen-
tal juncture between cardiac mesoderm and committed cardiac pro-
genitors is characterized by enrichment of integrin signaling-related
genes, including expression of specific collagens. A previous study
showed that day 6 of cardiac differentiation is the optimal time win-
dow for in vivo engraftment for hESC-derived cardiac progenitors,11
which may partly be explained by the expression of extracellular
matrix-related genes at this time point.
The in vitro-derived cardiac populations have previously been
associated with fetal cardiac lineages based on marker genes and elec-
trophysiological properties. Comparison between human in vivo and
in vitro-generated cells in single-cell resolution provides an attractive
method for the confirmation of population identities. We used this
approach to verify the identity of hESC-derived cells using trans-
criptomic data from human embryonic heart.1 During mammalian
heart development, atrial genes (eg, MYL4 and MYL7) are broadly
expressed in both atria and ventricles, and later their expression
becomes restricted to the atria.28 In line with these findings, we found
that cardiomyocytes collected on day 15 of cardiac differentiation
matched transcriptionally best with human fetal ventricular
cardiomyocytes, whereas the day-8 and day-9 progenitors, which
later differentiated into ventricular cardiomyocytes, resembled fetal
atrial cardiomyocytes. Earlier in vitro progenitors were developmen-
tally more immature than the earliest cells that can feasibly be col-
lected from human fetal hearts, highlighting the relevance of in vitro
cardiac induction as a model system for the early human heart
development.
Previous single-cell studies have reported definitive endoderm,
outflow tract fibroblast, endothelial, mesenchymal, ectoderm, and
neural crest populations in hESC cardiac induction.12,13 The role of
endoderm in cardiac lineage specification in in vivo heart development
is well established,39,40 and the presence of definitive endoderm pop-
ulation in the in vitro differentiation suggests that endoderm plays a
role in the hESC cardiac induction. The previous studies have not
comprehensively shown how the cardiac fibroblast-like cells relate to
the cardiac differentiation trajectory.
Cardiac fibroblasts comprise a significant fraction of nonmyogenic
cells in the mammalian heart41 and are an attractive cell population
for multiple purposes, such as tissue engineering. However, due to
heterogeneity and lack of specific lineage markers, their function
remains relatively unknown compared with other major cardiac cell
types. We identified an in vitro-derived cardiac fibroblast-like popula-
tion showing similar transcriptional profiles with human in vivo cardiac
fibroblasts, and identified TGFBI as a candidate marker for these cells.
Previous studies have indicated that the Wnt-modulation based car-
diac induction protocol generates cardiac fibroblast-like cells,13,42 but
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their lineage has remained elusive. In the in vivo setting, majority of
the cardiac fibroblasts arise from epicardium,43-45 and some from
endocardium46,47 and neural crest.46,48 Our lineage map suggests that
the cardiac fibroblast-like population arise from a lineage trajectory
that is separate from the myogenic lineage.
ISL1 has an important role regulating heart development30,34,49 as
well as in other organs,50,51 and indeed, we found ISL1 is expressed in both
myogenic and nonmyogenic progenitors. Our genetic perturbation study
indicated that ISL1 depletion partially redirects the myogenic cell fate
toward nonmyogenic identities. Interestingly, ISL1 deletion decreased the
expression of extracellular matrix organization-related genes, which char-
acterize the transition of cardiac mesoderm into cardiac progenitors. The
robust enrichment of neural progenitors in ISL1 KO differentiation sug-
gests that ISL1 may play an inhibitory role of a neural program in cardiac
progenitors, although ISL1 is required for motor neuron specification.50
5 | CONCLUSION
Our single-cell analysis uncovered developmental trajectories and lin-
eage branching points of myogenic and nonmyogenic progenitors dur-
ing hESC cardiac induction. The hESC cardiac differentiation is a
useful model system for studying ISL1+ early cardiac progenitors, and
our analysis further indicates ISL1 may be required to suppress a
neural-like cell fate in myogenic progenitors.
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